J&J Renews Commitment To Devices With Synthes Deal

Rumors that Johnson & Johnson was looking to exit cardiovascular devices and perhaps go so far as to divest their entire device business apparently can be put to rest in light of the company’s recently announced plans to acquire orthopedics leader Synthes Inc.